How to Add Peptides to Your Telehealth Brand After the 2026 HHS Notice
Short answer: To add peptides to an existing telehealth brand after the 10-28-2026 HHS notice, confirm pharmacy readiness for each of the six covered peptides, have providers write protocols, update intake, consent and product pages with claim-free copy, check LegitScript and processor rules, then launch to your existing audience first.
Why existing brands can move fastest
If your brand already runs on licensed providers, a compounding pharmacy partner, a patient portal and compliant payments, adding the six peptides covered by the HHS notice is a formulary expansion, not a new launch. On Wednesday, October 28, 2026, the U.S. Department of Health and Human Services announced temporary enforcement discretion for six peptides: BPC-157, TB-500, Epitalon, KPV, MOTS-c and Semax. In plain terms, the FDA will not take action against licensed compounding pharmacies that make these six while it completes formal rulemaking on whether to add them to the list of bulk drug substances pharmacies may use. Pharmacies that compound them are expected to certify the identity and purity of what they make and to report side effects. The notice was reported as scheduled for publication in the Federal Register on Friday, October 30, 2026.
Step 1: confirm pharmacy readiness
Ask your pharmacy partner, in writing, which of the six it will compound, in which forms, with what lead times, and how it documents identity and purity. Ask how it handles side-effect reports. If your pharmacy is not ready, ask your platform which licensed partners are.
Step 2: provider protocols and intake
Your providers decide whether and how each peptide fits your care model. They should write screening criteria, contraindication checks and follow-up cadence, and your intake should collect what they need. Some patients will be told no. That is a feature of a durable brand.
Step 3: product pages, consent and claims
Write each product page around the program and process, not outcomes. State clearly that the medication is compounded and not FDA approved, that a licensed provider decides, and that availability can change. Remove any copy that implies healing, recovery or anti-aging results.
Step 4: LegitScript, processors and ads
Confirm your LegitScript certification scope and your payment processor's rules cover the category before you take orders. Keep ad creative education-first. Expect ad platforms to review peptide content closely.
Step 5: launch to your own audience first
Your existing patients and list already trust you. Announce the program to them with accurate copy, then expand. GrowPro founders can add all six to their brand as an add-on; book a call and the team sets it up on the platform you already run.
Already a GrowPro founder? All six peptides can be added to the brand you run today. Talk to our team.
Frequently asked questions
How long does it take to add peptides to an existing telehealth brand?
For a brand already running on licensed providers and a pharmacy partner, it is mainly protocol, formulary and page work, often a matter of weeks, depending on pharmacy readiness and review.
Do I need new LegitScript certification for peptides?
Check your current certification scope and your processor's rules before launch. Some brands need an update; your launch partner or LegitScript can confirm.
Can I market peptides on Meta or Google?
Ad platforms restrict prescription and compounded drug advertising and usually require LegitScript certification. Education-first creative without benefit claims is the safest approach, and approvals are not guaranteed.
Sources
- NBC News, October 28, 2026
- STAT, October 28, 2026
- FDA: What telehealth companies should know when promoting compounded drugs
This article is general education, not legal or medical advice. The six peptides named here are not FDA-approved drugs, and the HHS enforcement discretion is temporary and may change. Confirm current status with your pharmacy partner and healthcare counsel.